What You Should Know: - Amwell, a leader in digital healthcare enablement, today announced the expansion of its digital clinical programs to include a cardiometabolic program, enabling health plans and clinicians to seamlessly connect members living with common chronic diseases, such as diabetes and high blood pressure, to Dario’s highly personalized digital therapeutic solution on the Amwell platform. - In partnership with personalized global digital therapeutic
Read More
DarioHealth
DarioHealth Integrates Dexcom CGM Data into Diabetes Platform
What You Should Know: - DarioHealth announced a partnership with Dexcom, the global leader in real-time continuous glucose monitoring (CGM) technology, to integrate its market-leading CGM data into Dario's multi-chronic condition platform. - Dexcom CGM uses a small, wearable sensor to continuously measure and send glucose levels to a receiver or smart device, enabling people with diabetes to make real-time decisions about their health. This agreement enables the integration
Read More
DarioHealth Forms $30M Strategic Agreement with Sanofi U.S.
What You Should Know: - DarioHealth Corp., a provider of global digital therapeutics (DTx), announced it has entered into a $30M multi-year, strategic agreement with Sanofi U.S., an innovative global healthcare company. The multi-year, $30 million-dollar agreement will help accelerate commercial adoption of Dario's full suite of digital therapeutics and drive the expansion of digital health solutions on the Dario platform. - As part of the strategic agreement, Dario and Sanofi will
Read More
DarioHealth Acquires Physimax, AI-Powered Musculoskeletal Self-Assessment and Optimization Platform
What You Should Know: - Global digital therapeutics (DTx) company DarioHealth Corp. (Nasdaq: DRIO), a leader in the market (the Company), announced it has entered into an agreement to purchase all of the right, title and interest in certain assets of Physimax Technologies Ltd. ("Physimax"), a leading provider of computer vision (CV) technology for Musculoskeletal (MSK) functional screening and predictive risk of injury assessment. - This acquisition complements DarioHealth’s existing MSK
Read More
HLTH21: DarioHealth Unveils its Digital Musculoskeletal Solution
What You Should Know: - DarioHealth Corp., a provider of digital therapeutics (DTx) solutions, announced today the launch of Dario Move, a new digital-physical therapy solution to manage common musculoskeletal (MSK) conditions that drive significant costs for employers and health plans. - With the addition of Dario Move, Dario's full suite is now positioned to support comprehensive chronic condition management across three of the top priorities for employers: diabetes, behavioral health
Read More
DarioHealth Acquires Digital Behavioral Health Platform wayForward for $30M
What You Should Know: - DarioHealth Corp., a pioneer in the global digital therapeutics market, today announced it has entered into an agreement to acquire PsyInnovations, Inc. (dba wayForward), a behavioral health digital platform that includes AI-enabled screening to triage and navigate members to specific interventions, digital Cognitive Behavioral Therapy (CBT), self-directed care, expert coaching and access to in-person and telehealth provider visits. - The wayForward platform
Read More
DarioHealth Acquires Musculoskeletal Solution Upright for $31M
What You Should Know: - DarioHealth, a Livongo competitor acquires musculoskeletal startup Upright for $31 million to expand their chronic condition management capabilities focused on driving behavior change rather than treating the acute problem. This move will more than double revenue and create one of the largest integrated digital health companies in the space. In addition, DarioHealth rasiess $70 million through a private placement of its common stock priced at the market pursuant to
Read More
DarioHealth Selected as Digital Chronic Care Solution by Self Insured, Fortune 500 Company
What You Should Know: - DarioHealth Corp., a pioneer in the global digital therapeutics market, announced today that it has signed a contract to provide its digital therapeutics solution to eligible employees of a U.S.-based Fortune 500 technology company. - Dario's top-rated digital diabetes tools and coaching will be available to eligible employees and their dependents starting January 1, 2021 - Dario helps manage and improve the health of people living with chronic conditions such
Read More
DarioHealth, Williams Medical Partner to Expand Digital Therapeutics Platform Across the UK and Ireland
What You Should Know: - Dario Health enters strategic partnership with Williams Medical marking its expansion into the UK remote patient monitoring market across the UK and Ireland. - Williams Medical is the leading provider of medical goods and services to primary care in the UK, and this agreement supports both companies' commitment to drive growth and deliver innovative solutions to frontline healthcare. DarioHealth Corp., a pioneer in the global digital therapeutics market,
Read More
DarioHealth Closes $21.3M to Expand Digital Therapeutics Platform Beyond Diabetes & Hypertension
- DarioHealth closed on a private placement of $21.3M in convertible preferred stock to institutional and private investors.- Proceeds of the financing will be deployed to accelerate B2B partnerships with payer organizations who can commit subscribers in the thousands, to reinforce D2C, and to expand their product lineup beyond their current diabetes and hypertension offering.Global digital therapeutics innovation provider, DarioHealth Corp. (NASDAQ: DRIO), announced that it has closed on a
Read More
